Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 3, 2006, Pages 288-296

  Van Heeckeren, Anna M ^a,b   Schluchter, Mark D ^a   Xue, Wei ^a   Davis, Pamela B ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Inflammation; Pathogenesis

Indexed keywords

AUTACOID; CHLORIDE CHANNEL;

AERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CHRONIC LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; IMMUNE RESPONSE; INFLAMMATION; LUNG; LUNG INFECTION; LUNG LAVAGE; MORPHOMETRICS; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCORING SYSTEM; SEPSIS; SURVIVAL TIME; WEIGHT CHANGE; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOKINES; DISEASE MODELS, ANIMAL; MICE; MICE, CONGENIC; MICE, INBRED CFTR; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS;

EID: 32144455216     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200506-917OC     Document Type: Article

References (28)

1. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary in.ammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151:1075-1082.
2. Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R. The relationship between infection and in.ammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995;20:63-70.
3. Grubb BR, Vick RN, Boucher RC. Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl- secretion in nasal epithelia of CF mice. Am J Physiol 1994;266:C1478-C1483.
4. Noah TL, Black HR, Cheng PW, Wood RE, Leigh MW. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 1997;175:638-647.
5. Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of in.ammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999;160:186-191.
6. Mall M, Grubb BR, Harkema JR, O'Neal WK, Boucher RC. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med 2004;10:487-493.
7. Davidson DJ, Dorin JR, McLachlan G, Ranaldi V, Lamb D, Doherty C, Govan J, Porteous DJ. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat Genet 1995;9:351-357.
8. Koehler DR, Sajjan U, Chow YH, Martin B, Kent G, Tanswell AK, McKerlie C, Forstner JF, Hu J. Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia. Proc Natl Acad Sci USA 2003;100:15364-15369.
9. Sajjan U, Thanassoulis G, Cherapanov V, Lu A, Sjolin C, Steer B, Wu YJ, Rotstein OD, Kent G, McKerlie C, et al. Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice. Infect Immun 2001;69:5138-5150.
10. George SE, Kohan MJ, Gilmour MI, Taylor MS, Brooks HG, Creason JP, Claxton LD. Pulmonary clearance and in.ammatory response in C3H/ HeJmice after intranasal exposure to Pseudomonas spp. Appl Environ Microbiol 1993;59:3585-3591.
11. Gosselin D, Stevenson MM, Cowley EA, Griesenbach U, Eidelman DH, Boule M, Tam MF,Kent G, Skamene E, Tsui LC, et al. Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa. Am J Respir Crit Care Med 1998;157:1253-1262.
12. Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, Ferkol T. Excessive in.ammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 1997;100:2810-2815.
13. van Heeckeren AM, Scaria A, Schluchter MD, Ferkol TW, Wadsworth S, Davis PB. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection. Am J Physiol Lung Cell Mol Physiol 2004;286:L717-L726.
14. McMorran BJ, Palmer JS, Lunn DP, Oceandy D, Costelloe EO, Thomas GR, Hume DA, Wainwright BJ. G551D CF mice display an abnormal host response and have impaired clearance of Pseudomonas lung disease. Am J Physiol Lung Cell Mol Physiol 2001;281:L740-L747.
15. Chroneos ZC, Wert SE, Livingston JL, Hassett DJ, Whitsett JA. Role of cystic fibrosis transmembrane conductance regulator in pulmonary clearance of Pseudomonas aeruginosa in vivo. J Immunol 2000;165:3941-3950.
16. van Heeckeren AM, Downey G, Davis PB. Towards a novel model of chronic P. aeruginosa lung infection in CF mice [abstract]. Pediatr Pulmonol Suppl 2003;25:227.
17. van Heeckeren AM, Downey G, Davis PB. Modeling the natural pathophysiology of P. aeruginosa lung infection in CF mice [abstract]. Pediatr Pulmonol Suppl 2003;25:287.
18. van Heeckeren AM, Schluchter MD, Drumm ML, Davis PB. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 2004;287:L944-L952.
19. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986;60:532-538.
20. van Heeckeren A, Ferkol T, Tosi M. Effects of bronchopulmonary in.ammation induced by pseudomonas aeruginosa on adenovirusmediated gene transfer to airway epithelial cells in mice. Gene Ther 1998;5:345-351.
21. Nader-Djalal N, Knight PR, Bacon MF, Tait AR, Kennedy TP, Johnson KJ. Alterations in the course of acid-induced lung injury in rats after general anesthesia: volatile anesthetics versus ketamine. Anesth Analg 1998;86:141-146.
22. Shayevitz JR, Rodriguez JL, Gilligan L, Johnson KJ, Tait AR. Volatile anesthetic modulation of lung injury and outcome in a murine model of multiple organ dysfunction syndrome. Shock 1995;4:61-67.
23. van Heeckeren AM, Schluchter M, Xue L, Alvarez J, Freedman S, St.George J, Davis PB. Nutritional effects on host response to lung infections with mucoid Pseudomonas aeruginosa in mice. Infect Immun 2004;72:1479-1486.
24. Schroeder TH, Reiniger N, Meluleni G, Grout M, Coleman FT, Pier GB. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract. J Immunol 2001;166:7410-7418.
25. Grubb BR, Paradiso AM, Boucher RC. Anomalies in ion transport in CF mouse tracheal epithelium. Am J Physiol 1994;267:C293-C300.
26. Cressman VL, Hicks EM, Funkhouser WK, Backlund DC, Koller BH. The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice. Am J Respir Cell Mol Biol 1998;19:853-866.
27. Walker TS, Tomlin KL, Worthen GS, Poch KR, Lieber LG, Saavedra MT, Fessler MB, Malcolm KC,Vasil ML,Nick JA.Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 2005;73:3693-3701.
28. Hoffmann N, Rasmussen TB, Jensen PO, Stub C, Hentzer M, Molin S, Ciofu O, Givskov M, Johansen HK, Hoiby N. Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect Immun 2005;73:2504-2514.